StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Valeant Pharma (VRX): Brodalumab Suicide Rate is 3-4x Higher Than Other Biologics - Mizuho
July 15, 2016 9:18 AM
Mizuho Securities analyst, Irena Koffler, performed an initial read of the briefing documents and her take is not great: The ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
FDA
Hot FDA News
Next Articles
Valeant Pharma (VRX) AdCom on Brodalumab Begins
July 19, 2016 8:10 AM
Briefing Docs Show Valeant Pharma (VRX) Brodalumab Prospects are Dim - Wells Fargo
July 15, 2016 1:09 PM